arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2202.07096cs.AI
收藏

学习发现药物

Learning to Discover Medicines

Applied Artificial Intelligence Institute, Deakin University(迪肯大学应用人工智能研究所);Deakin University(迪肯大学);Australia(澳大利亚(注意:这里原文本中“Australia”是国家,非机构,根据提取范围,应排除,所以正确的只有前两个))

Tri Minh Nguyen, Thin Nguyen, Truyen Tran

摘要:

发现新药是人类努力过上更好、更长寿生活的标志。然而,发现的步伐已经放缓,因为我们需要冒险进入更广泛的未开发的生物医学空间,以找到一个符合今天的高标准。现代人工智能由强大的计算、大型生物医学数据库和深度学习的突破所支持,随着人工智能的迅速成熟,它为打破这一循环提供了新的希望,并准备在该领域产生巨大的影响。在本文中,我们回顾了旨在解决这一挑战的人工智能方法的最新进展。我们将用于药物发现的大量且快速增长的人工智能文献分为三个相对稳定的子领域:(a)分子序列和几何图形的表示学习;(b)数据驱动的推理,我们预测分子特性及其结合,优化现有化合物,生成从头分子,并计划目标分子的合成;(c)基于知识的推理,讨论了生物医学知识图谱的构建和推理。我们还将确定开放的挑战,并绘制未来几年可能的研究方向。

英文摘要:

Discovering new medicines is the hallmark of human endeavor to live a better and longer life. Yet the pace of discovery has slowed down as we need to venture into more wildly unexplored biomedical space to find one that matches today's high standard. Modern AI-enabled by powerful computing, large biomedical databases, and breakthroughs in deep learning-offers a new hope to break this loop as AI is rapidly maturing, ready to make a huge impact in the area. In this paper we review recent advances in AI methodologies that aim to crack this challenge. We organize the vast and rapidly growing literature of AI for drug discovery into three relatively stable sub-areas: (a) representation learning over molecular sequences and geometric graphs; (b) data-driven reasoning where we predict molecular properties and their binding, optimize existing compounds, generate de novo molecules, and plan the synthesis of target molecules; and (c) knowledge-based reasoning where we discuss the construction and reasoning over biomedical knowledge graphs. We will also identify open challenges and chart possible research directions for the years to come.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑